Cytokinetics (CYTK) Non-Current Assets (2016 - 2025)
Historic Non-Current Assets for Cytokinetics (CYTK) over the last 15 years, with Q3 2024 value amounting to $417.5 million.
- Cytokinetics' Non-Current Assets rose 13295.96% to $417.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.2 billion, marking a year-over-year increase of 5463.43%. This contributed to the annual value of $196.3 million for FY2023, which is 1062.17% down from last year.
- Cytokinetics' Non-Current Assets amounted to $417.5 million in Q3 2024, which was up 13295.96% from $456.0 million recorded in Q2 2024.
- Over the past 5 years, Cytokinetics' Non-Current Assets peaked at $456.0 million during Q2 2024, and registered a low of $13.5 million during Q2 2020.
- In the last 5 years, Cytokinetics' Non-Current Assets had a median value of $193.3 million in 2023 and averaged $198.7 million.
- Its Non-Current Assets has fluctuated over the past 5 years, first soared by 137753.49% in 2021, then plummeted by 4236.71% in 2022.
- Over the past 5 years, Cytokinetics' Non-Current Assets (Quarter) stood at $59.6 million in 2020, then soared by 412.99% to $305.6 million in 2021, then decreased by 28.16% to $219.6 million in 2022, then decreased by 10.62% to $196.3 million in 2023, then skyrocketed by 112.7% to $417.5 million in 2024.
- Its Non-Current Assets was $417.5 million in Q3 2024, compared to $456.0 million in Q2 2024 and $169.4 million in Q1 2024.